Evolus (EOLS) Cost of Revenue (2019 - 2026)
Evolus (EOLS) posted Cost of Revenue of $24.2 million for Q1 2026, down 21.83% on a QoQ basis from $31.0 million in Q4 2025, and up 10.85% year-over-year from $21.9 million in Q1 2025.
Evolus (EOLS) Cost of Revenue (2019 - 2026) Analysis & Trends
Evolus' Cost of Revenue history runs 8 years deep, the most recent figure standing at $24.2 million for Q1 2026.
- Quarterly Cost of Revenue rose 10.85% year-over-year to $24.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $102.4 million (up 17.74% YoY) and the FY2025 annual result came in at $100.1 million, up 19.17% from the prior year.
- Cost of Revenue was $24.2 million for Q1 2026 at Evolus, down from $31.0 million in the prior quarter.
- Across five years, Cost of Revenue topped out at $31.0 million in Q4 2025 and bottomed at $12.1 million in Q1 2023.
- A 5-year average of $19.5 million and a median of $19.0 million in 2024 frame the typical range for Cost of Revenue.
- Annual changes were most pronounced in 2022 — Cost of Revenue soared 169.11% — and 2023, when it slipped 8.04%.
- Evolus' Cost of Revenue stood at $16.3 million in 2022, then soared by 36.14% to $22.2 million in 2023, then grew by 18.39% to $26.3 million in 2024, then rose by 17.85% to $31.0 million in 2025, then dropped by 21.83% to $24.2 million in 2026.
- Business Quant data shows EOLS's Cost of Revenue at $24.2 million in Q1 2026, $31.0 million in Q4 2025, and $23.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 2.01 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 641.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 2.59 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 133.40 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 2.36 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 13.80 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 586.00 Mn |
| 10 | Evolus | 403.51 Mn | 353.71 Mn | 48.90 Mn | 24.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.24 Mn |
| Mar 31, 2026 | 24.24 Mn |
| Dec 31, 2025 | 31.01 Mn |
| Dec 31, 2025 | 31.01 Mn |
| Sep 30, 2025 | 23.13 Mn |
| Sep 30, 2025 | 23.13 Mn |
| Jun 30, 2025 | 24.07 Mn |
| Jun 30, 2025 | 24.07 Mn |
| Mar 31, 2025 | 21.87 Mn |
| Mar 31, 2025 | 21.87 Mn |
| Dec 31, 2024 | 26.31 Mn |
| Dec 31, 2024 | 26.31 Mn |
| Sep 30, 2024 | 18.99 Mn |
| Sep 30, 2024 | 18.99 Mn |
| Jun 30, 2024 | 19.84 Mn |
| Jun 30, 2024 | 19.84 Mn |
| Mar 31, 2024 | 18.83 Mn |
| Mar 31, 2024 | 18.83 Mn |
| Dec 31, 2023 | 22.23 Mn |
| Dec 31, 2023 | 22.23 Mn |